Edition:
United States

Catabasis Pharmaceuticals Inc (CATB.OQ)

CATB.OQ on NASDAQ Stock Exchange Global Market

0.82USD
12:29pm EDT
Change (% chg)

$-0.00 (-0.59%)
Prev Close
$0.82
Open
$0.84
Day's High
$0.84
Day's Low
$0.81
Volume
11,308
Avg. Vol
112,340
52-wk High
$3.78
52-wk Low
$0.78

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.288
FY 2017 Dec '17 0.25 -0.237
Sep '17 0.25 -0.311
Jun '17 0.00 -0.320
Mar '17 0.00 -0.412
FY 2016 Dec '16 0.00 -0.469
Sep '16 0.00 -0.543
Jun '16 0.00 -0.614
Mar '16 0.00 -0.614
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 2 0.00 0.00 0.00 0.00
Quarter Ending Dec-18 2 0.00 0.00 0.00 0.00
Year Ending Dec-18 2 0.00 0.00 0.00 0.00
Year Ending Dec-19 2 0.00 0.00 0.00 0.72
Earnings (per share)
Quarter Ending Sep-18 3 -0.20 -0.11 -0.31 -0.46
Quarter Ending Dec-18 3 -0.19 -0.07 -0.31 -0.47
Year Ending Dec-18 3 -0.90 -0.63 -1.22 -1.48
Year Ending Dec-19 3 -1.11 -0.22 -1.90 -1.76
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 214.90 33.15
P/E High - Last 5 Yrs. -- 284.62 47.15
P/E Low - Last 5 Yrs. -- 97.26 25.03
Beta -- 0.76 0.82
Price to Sales (TTM) 120.76 249.52 8.04
Price to Book (MRQ) 1.84 20.91 4.28
Price to Tangible Book (MRQ) 4.67 27.67 6.01
Price to Cash Flow (TTM) -- 128.44 22.37
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.72
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.26 -6.51
Payout Ratio(TTM) -- 81.45 47.12

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 33.19 4.77
Sales (TTM) vs TTM 1 Yr. Ago -- 147.62 12.38
Sales - 5 Yr. Growth Rate -- 30.71 7.73
EPS (MRQ) vs Qtr. 1 Yr. Ago 30.15 -75.18 45.88
EPS (TTM) vs TTM 1 Yr. Ago 43.32 -- --
EPS - 5 Yr. Growth Rate -- 47.08 7.99
Capital Spending - 5 Yr. Growth Rate -30.83 42.68 7.69

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.72 2.57
Current Ratio (MRQ) 3.40 6.59 3.65
LT Debt to Equity (MRQ) 0.00 23.42 13.25
Total Debt to Equity (MRQ) 12.81 27.63 17.43
Interest Coverage (TTM) -66.24 -152.82 35.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.03 55.10
Gross Margin - 5 Yr. Avg. -- 53.54 53.12
EBITD Margin (TTM) -5,338.80 -- --
EBITD - 5 Yr. Avg -26,528.40 -181.32 15.67
Operating Margin (TTM) -5,394.40 -951.60 -0.48
Operating Margin - 5 Yr. Avg. -26,822.20 -194.98 10.86
Pre-Tax Margin (TTM) -5,428.00 -847.04 1.32
Pre-Tax Margin - 5 Yr. Avg. -27,211.20 -199.53 10.99
Net Profit Margin (TTM) -5,428.00 -838.46 -1.97
Net Profit Margin - 5 Yr. Avg. -27,211.20 -197.33 7.35
Effective Tax Rate (TTM) -- 14.88 20.80
Effective Tax Rate - 5 Yr. Avg. -- 19.11 24.26

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,459,372 746,896,227
Net Income/Employee (TTM) -- -837,623 87,146,227
Receivable Turnover (TTM) -- 17.81 5.99
Inventory Turnover (TTM) -- 2.84 3.70
Asset Turnover (TTM) 0.02 0.48 0.88

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -104.97 3.13 10.49
Return on Assets - 5 Yr. Avg. -83.24 2.92 11.10
Return on Investment (TTM) -139.40 -3.85 13.23
Return on Investment - 5 Yr. Avg. -99.87 2.71 14.34
Return on Equity (TTM) -147.16 -5.38 15.27
Return on Equity - 5 Yr. Avg. -- -3.29 15.70
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 43.19 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Catabasis Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 41.50%
# of Holders: 35
Total Shares Held: 29,477,302
3 Mo. Net Change: 18,868,316
# New Positions: 3
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 0
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.